Mostrar el registro sencillo

dc.contributor.authorCalderón Parra, Jorge
dc.contributor.authorKestler, Martha
dc.contributor.authorRamos Martínez, Antonio
dc.contributor.authorBouza, Emilio
dc.contributor.authorValerio, Maricela
dc.contributor.authorAlarcón González, Arístides de
dc.contributor.authorLuque, Rafael
dc.contributor.authorGoenaga, Miguel Ángel
dc.contributor.authorEchevarría, Tomás
dc.contributor.authorFariñas Álvarez, María del Carmen 
dc.contributor.authorPericàs, Juan M.
dc.contributor.authorOjeda Burgos, Guillermo
dc.contributor.authorFernández Cruz, Ana
dc.contributor.authorPlata, Antonio
dc.contributor.authorVinuesa, David
dc.contributor.authorMuñoz, Patricia
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-03-28T15:51:25Z
dc.date.available2022-03-28T15:51:25Z
dc.date.issued2021-02-13
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10902/24412
dc.description.abstractWe aimed to identify clinical factors associated with recurrent infective endocarditis (IE) episodes. The clinical characteristics of 2816 consecutive patients with definite IE (January 2008?2018) were compared according to the development of a second episode of IE. A total of 2152 out of 2282 (94.3%) patients, who were discharged alive and followed-up for at least the first year, presented a single episode of IE, whereas 130 patients (5.7%) presented a recurrence; 70 cases (53.8%) were due to other microorganisms (reinfection), and 60 cases (46.2%) were due to the same microorganism causing the first episode. Thirty-eight patients (29.2%), whose recurrence was due to the same microorganism, were diagnosed during the first 6 months of follow-up and were considered relapses. Relapses were associated with nosocomial endocarditis (OR: 2.67 (95% CI: 1.37?5.29)), enterococci (OR: 3.01 (95% CI: 1.51?6.01)), persistent bacteremia (OR: 2.37 (95% CI: 1.05?5.36)), and surgical treatment (OR: 0.23 (0.1?0.53)). On the other hand, episodes of reinfection were more common in patients with chronic liver disease (OR: 3.1 (95% CI: 1.65?5.83)) and prosthetic endocarditis (OR: 1.71 (95% CI: 1.04?2.82)). The clinical factors associated with reinfection and relapse in patients with IE appear to be different. A better understanding of these factors would allow the development of more effective therapeutic strategies.es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Clinical Medicine 2021, 10, 748es_ES
dc.subject.otherEndocarditises_ES
dc.subject.otherBacteriales_ES
dc.subject.otherRecurrencees_ES
dc.subject.otherEnterococcuses_ES
dc.subject.otherBacteremiaes_ES
dc.subject.otherCardiac surgical procedureses_ES
dc.subject.otherLiver diseasees_ES
dc.titleClinical Factors Associated with Reinfection versus Relapse in Infective Endocarditis: Prospective Cohort Studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/jcm10040748es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOIdoi.org/10.3390/jcm10040748
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2021 by the authors. Licensee MDPI, Basel, Switzerland.